David Matthew T 4
4 · CorMedix Inc. · Filed Jan 13, 2021
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2021-01-11+80,000→ 80,000 totalExercise: $8.32Exp: 2031-01-11→ Common Stock (80,000 underlying)
Holdings
- 1,150
Common Stock
- 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $4.08Exp: 2030-05-11→ Common Stock (125,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-05-11→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
- [F2]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.